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Background: Pathologic fractures of the femoral intertrochanteric and subtrochanteric region require special
consideration in terms of biomechanically stable fixation and durability of the implant. In addition, the type of
surgery might also influence patient survival. We conducted this retrospective study to evaluate the safety of
modular proximal femur replacement compared to intramedullary nailing with patient survival being the primary
and complications the secondary endpoint.
Methods: We retrospectively studied the records of 20 consecutive patients with actual pathologic fracture due to
bone metastasis in the intertrochanteric and subtrochanteric part of the femur. The pathologic fractures were
stabilized with a locked cephalomedullary nail in 12 patients and treated with en-bloc resection and modular
proximal femur replacement in eight patients.
Results: In the tumor prosthesis group median patient survival was more than twice as high (4.5 months, IQR
2.3 – 16.5) than in the osteosynthesis group (2.0 months, IQR 0.3 – 20.5), but did not reach significance (p = 0.58).
Besides, a significantly better preoperative general health status in patients with endoprosthetic reconstruction puts
better survival into perspective. Median implant survivorship did not differ between groups with 2.5 (IQR 1.0 – 7.5)
months for endoprothesis and 3.0 (IQR 0.3 – 11.0) months for osteosynthesis (p = 0.93). Complication rates were
comparable with 25% in each group.
Conclusion: Patient survival was not influenced by type of surgery or choice of implant. Preoperative general
health condition and ambulatory capacity may aid in decision for type of surgery and improve patient safety,
respectively.
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The most frequent site of extravertebral osseous meta-
static lesions is located in the femur, specifically in the
proximal part of it [1-3]. Bone metastases of the femoral
head and neck with subsequent fractures usually are
treated with conventional arthroplasty [4]. On the con-
trary, pathologic fractures of the trochanteric region not
only necessitate restoration of hip function, but also* Correspondence: johannes.fakler@medizin.uni-leipzig.de
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stated.demand full weight-bearing capacity to the femoral di-
aphysis. Hence, pathologic fractures of the femoral inter-
trochanteric and subtrochanteric region require special
consideration in terms of biomechanically stable fixation
of the implant and restoration of lower limb function
[4,5]. Since healing of pathologic fractures can be ex-
pected in only about 35% of all pathologic fractures [6],
durable reconstitution of load capacity in this biomech-
anically critical region must be provided by the implant
itself in many cases. Apart from technical aspects,
variable general health condition and indistinct survival
time of patients with secondary osseous tumor lesionstd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited. The Creative Commons Public Domain Dedication
ain/zero/1.0/) applies to the data made available in this article, unless otherwise
Figure 1 Distribution of cancer types.
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surgical procedure and choice of implant. Although pre-
vious studies reported on strategies and outcome, op-
timal treatment is still under debate. Recently it was
demonstrated, that patient survival may benefit from re-
section and modular replacement with a tumor pros-
thesis compared to intramedullary nailing in pathologic
fracture of the proximal femur [5]. We conducted this
retrospective study to evaluate the safety of modular
proximal femur replacement compared to intramedu-
llary nailing in the treatment of pathologic trochanteric
femoral fracture with respect to survival time of patients
and implants as well as complications.
Methods
We retrospectively studied the records of 20 consecutive
patients with pathologic fractures due to bone metastasis
in the intertrochanteric and subtrochanteric part of the
femur at the author’s institution from January 2003 to
December 2012. Patients with an impending fracture as
well as patients with a solitary metastasis were excluded
for better reproducibility. All patients gave written con-
sent for scientific analysis of their data. All bone metas-
tases were confirmed by biopsy. All values are given as
median values and the interquartile range IQR (25th-75th
percentile). Median age of all patients was 69.8 years
(IQR 61.8 – 74.0). Nine patients were female and ele-
ven male. The median postoperative follow-up was 3.0
months (IQR 1.0 – 18.3). No patient was lost to follow-
up. In order to estimate the general health condition
preoperatively the Karnofsky performance status was
used [10]. A performance status of 80-100% was re-
garded as a good general health condition, 50-79% as
moderate and 10-49% as poor. Walking ability was sub-
divided in three groups: ambulatory without any walking
aids, ambulatory with walking aids and not ambulatory
(wheel-chair or bed-bound). 15 of 20 patients (75%) also
had vertebral metastases at the time of pathologic pro-
ximal femoral fracture. Hence, the Tokuhashi-Score was
calculated to predict patient survival [11].
The breast was the most common site of the pri-
mary tumor (35%), followed by prostate cancer, multiple
myeloma and cancer of unknown origin with each 10%
(Figure 1).
Operative treatment
The pathologic fractures were stabilized with a locked
cephalomedullary nail in 12 patients in the osteosynthesis
group and treated with en-bloc resection and modular prox-
imal femur replacement in eight patients in the tumor pros-
thesis group. With respect to osteosynthetic stabilization
a proximal femoral antirotation nail with a spiral blade
(PFNA, Synthes, Oberdorf, Switzerland) was used in two
cases and cephalomedullary nail (Sirus, Zimmer, Freiburg,Germany) in the remaining ten patients. In three patients
curettage and cementation was performed addition-
ally. Two patients primarily treated with a cephalome-
dullary nail were converted to a cemented proximal
femoral replacement after early failure of the osteo-
synthesis three and five months after operation (cut out of
the cephalic screw and implant breakage). In eight pa-
tients the tumor prosthesis was implanted primarily. All
patients with resection received a cemented modular
proximal femoral replacement (MUTARS, Implantcast,
Buxtehude, Germany). Hemiarthroplasty as well as to-
tal arthroplasty was performed in four patients. A la-
teral approach was performed in all proximal femoral
replacements.
Survival analysis
The patient survival was assessed by the time interval
from operation until death or last follow-up for patients
alive. Implant survivorship was determined as the time
period from the operation until death, last follow-up of
patients alive or re-operation for any reason at the same
site of the operation. Implant durability was defined as
the time period from operation until death, last follow-
up, or implant exchange due to structural failure as for
secondary fracture dislocation, periimplant/periprosthetic
fracture, hardware failure or loosening.
Statistical analysis
Patient survival was defined as primary outcome with
implant survival and complications rates being secon-
dary endpoints. Correspondingly, our primary hypothesis
was that patient and implant survival is higher for mega-
endoprosthetic replacement compared to osteosynthesis.
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equality of groups cannot be assumed, subsequently a
power-analysis was not performed. Statistical analysis
was performed with the PASW software version 20
(SPSS Inc., Chicago, IL, USA). Comparison and testing
for differences in both groups was assessed with the
Mann-Whitney-U test. For patient and implant survival
the Kaplan-Meier analysis was applied, differences were
determined by log-rank analysis. Differences were con-
sidered statistically significant when the p value was less
than 0.05.
Results
Survival of all patients at six and twelve months was
45.0% and 35.0%, respectively. At two years three pa-
tients were alive (15.0%). At the last follow-up three
patients were still alive 22, 35 and 45 months after
operation.
The overall median preoperative Karnofsky perform-
ance status was 50% (IQR 40.0 – 77.5) and the Takahashi
Score 6.5 (IQR 6.0 – 8.0). Median length of operation
was 135 minutes (IQR 101 – 179) in the arthroplasty
group compared to 81 minutes (IQR 56 – 123) in the
osteosynthesis group (Table 1). In the tumor prosthesis
group median patient survival was more than twice as
high (4.5 months, IQR 2.3 – 16.5) than in the osteo-
synthesis group (2.0 months, IQR 0.3 – 20.5), but did
not reach significance (p = 0.58). Median implant sur-
vivorship which takes any complication into account,
did not differ between groups with 2.5 (IQR 1.0 – 7.5)
months for endoprothesis and 3.0 (IQR 0.3 – 11.0)
months for osteosynthesis (p = 0.93). With respect to im-
plant durability, referring only to complications asso-
ciated with the structural integrity of the implant (i.e.
breakage), superiority was seen for the endoprosthesis
(median 4.5, IQR 2.3 – 16.5) compared to the intrame-
dullary nail (median 2.0, IQR 0.3 – 11.0 months), but
the difference was also not significant (p = 0.31). Kaplan-
Meier analysis for patient survival, implant survivorship
and durability also failed to demonstrate a significant dif-
ference (Figure 2). Median time from first tumor diagnosisTable 1 Age, time periods and survival
Proximal
Age at operation (years) 61
Time from initial diagnosis to operation (months) 5
Patient survival since operation (months) 4
Implant survival (months)
Implant durability (months) 4
Patient survival since initial diagnosis (months) 65
Values are given as median values (interquartile range IQR). Implant survival reflects
Implant durability refers to the time from surgery until death, follow-up or revision
fracture, loosening, etc.).until fracture was 24.0 months (IQR 1.0 – 64.3) in the
osteosynthesis group and 54.5 months (IQR 4.8 – 87.3) in
the tumor prosthesis group (p = 0.43). Median age was sig-
nificantly lower (p = 0.03) in patients receiving a tumor
prosthesis (61.9 years, IQR 59.5 – 72.7) compared to the
osteosynthesis group (73.8, IQR 66.5 - 80.5). Preoperative
general state of health demonstrated by the Karnofsky
performance status also differed significantly in favor of
the prosthesis group (p = 0.01) and was judged moderate
vs. poor, respectively. This was confirmed by evaluating
preoperative ambulatory capacity. In the prosthesis group
all patients were able to walk, whereas in the internal fix-
ation group 58.3% of patients were wheel-chair or bed
bound (Table 2). The median Tokuhashi score was 7.0
(IQR 6.3 – 8.0) and 6.0 (IQR 5.3 – 7.8) in the prosthesis
and osteosynthesis group, respectively and did not differ
significantly (p = 0.2). No intraoperative deaths occurred
in either groups. Within the first 14 postoperative days
three patients in the osteosynthesis group and one patient
in the prosthesis group died. All preoperative ambulatory
patients surviving the first two postoperative weeks re-
sumed walking again (Table 2). Two patients in the intra-
medullary group complained about persistent pain. Both
of them suffered implant failure three and five months
postoperatively due to cut out and nail braekage. Conver-
sion to a tumor prosthesis was accomplished in these two
patients. The secondary implanted tumor prostheses re-
quired no surgical revision, although one patient deve-
loped a late deep infection with a fistula. This patient
refused surgical intervention. At the last follow-up in
22 months after operation the stable fistula persisted with
no additional systemic or local signs of infection. The pa-
tient is ambulatory and reports no pain, no signs of loos-
ening were evident on x-rays. The other patient with an
implant exchange died 28 months after revision. The third
patient with a complication after osteosynthesis necessi-
tated revision because of deep infection, accounting a for
total of three complications (25%). In the prosthesis group
two out of eight primary tumor prostheses (25%) needed
conversion from hemi- to total hip arthroplasty or revision
of the acetabular cup because of recurrent dislocation.femoral replacement Osteosynthesis p
.9 (59.5 – 72.7) 73.8 (66.5 – 80.4) < 0.05
4.5 (4.8 – 87.3) 24.0 (1.0 – 64.3) 0.43
.5 (2.3 – 16.5) 2.0 (0.3 – 20.5) 0.58
2.5 (1.0 – 7.5) 3.0 (0.3 – 11.0) 0.93
.5 (2.3 – 16.5) 2.0 (0.3 – 11.0) 0.31
.0 (10.8 – 112.0) 30.0 (1.5 – 87.5) 0.34
the time period from surgery until death, follow-up or revision for any reason.
for structural implant failure only (i.e. nail breakage, periimplant/periprosthetic
Figure 2 Survival curves. A) Patient survival. Kaplan-Meier curves showing survival for patients with proximal femoral replacement (blue) and
osteosynthesis (green). B) Implant survivorship. Kaplan-Meier curves demonstrating survivorship of proximal femoral replacement (blue) and
osteosynthesis with revision surgery for any reason at the site of primary surgery as an endpoint. C) Implant durability. Kaplan-Meier curves
demonstrating durability of proximal femoral replacement (blue) and osteosynthesis with implant exchange due to structutal implant failure.
Table 2 Preoperative health condition and ambulatory capacity
Proximal femoral replacement Osteosynthesis p
Karnofsky index 65.0 (52.5 – 90.0) 45.0 (30.0 – 50.0) < 0.05
Takahashi score 7.0 (6.3 – 8.0) 6.0 (5.3 – 7.8) 0.20
Ambulatory capacity preop. postop. preop. postop.
Normal (n) 3 1 4 1
With walking aids (n) 5 6 1 4
Wheel chair/bed bound (n) - 7 4
Values for the Karnofsky index and Takahashi score are given as median values (interquartile range IQR). Ambulatory capacity is demonstrated by number of
patients with different categories of mobility before and after surgery. Walking capacity was not evaluated in one patient after endoprothetic reconstruction and
in three patients after intramedullary nailing, because of progressive disease and early postoperative death.
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tube was not performed in these two patients.
An additional analysis was performed accounting the
two early osteosynthesis failures with implant exchange
to the prosthesis group. Nevertheless, no significant dif-
ferences with respect to patient survival and implant
survivorship were found.
Discussion
In terms of patient survival it is very difficult to estimate
the role of the surgical method or choice of implant.
Many cofactors have shown to influence patient survival
in metastatic bone disease as age, preoperative general
health status, type of cancer, location of metastasis in
the femur or solitary versus multiple metastases [11-14].
Apart from these factors actual fracture compared to im-
pending fracture in long bones seems to be another essen-
tial cause influencing patient survival [5,7]. Mavrogenis
et al. [5] demonstrated that impending fractures show a
significantly better life expectancy with survival rates of
approximately 60% at one year, 40% at two years, 30% at
three years and 20% after 5 years. Survival rates of actual
pathologic femoral fracture are reported to be approxi-
mately 45% at six months, 30% at one year, 15% at two
years and less than 10% after 3 years [4,5,15], correspond-
ing well to our results. Mavrogenis et al. additionally
found that the type of surgery is a significant factor in pa-
tient survival. This was also demonstrated for pathologic
fractures of the proximal femur. Patient survival was sig-
nificantly higher in 18 patients with proximal femoral re-
section and modular prosthetic replacement compared to
11 patients with intramedullary nailing [5]. According to
these results our primary hypothesis was to confirm su-
perior survival in patients undergoing proximal femoral
resection and endoprothetic reconstruction compared to
intramedullary osteosynthesis. Although we could see a
tendency to better survival in the prosthetic group it was
statistically not significant. Besides, preoperative general
health performance which is a substantial predictor of sur-
vival in skeletal metastases [11,12] was significantly lower
in the osteosynthesis group contributing to an earlier
death and putting a better survival by trend in the pros-
thesis group into perspective. Preoperative general health
performance was not reported by Mavrogenis et al. Con-
sequently, the benefit in patient survival after resection
and endoprosthesis in their study might be equivocal [5].
None of the patients in our series died because of in-
traoperative embolic events. It has been shown by others
that implantation of a long intramedullary nail or a
long-stem cemented femoral component in patients with
femoral metastasis increases the risk of an embolic syn-
drome considerably resulting in catastrophic outcome in
up to 8% [16-19]. We believe that cemented stems with
a regular length and modular reconstruction bushingsbridging the osseous defect as applied in our study may
help in reducing the risk of an embolic syndrome und
increase patient safety.
Complications requiring reoperation are reported to
be as high as 26% for intramedullary nailing and 18% for
endoprosthesic replacement in treatment of pathologic
fracture of the proximal femur [4,9]. This compares well
to our results with a complication rate of 25% in each
group. As for intramedullary nailing complication rates
might be substantially higher considering actual patho-
logic fractures exclusively. The rate of fracture union is
considerably less than 50% for common tumor types
such as breast and renal carcinoma or even absent as
demonstrated for lung carcinoma [6]. On the other hand
impending fractures proceed to fracture in only 13%
after local irradiation [20], subsequently load induced
stress to osteosynthetic devices and potential failure is
conspicuously lower. This is confirmed by Harvey et al.
[9] demonstrating a significantly higher complication
rate for intramedullary nails in actual pathologic frac-
tures than in impending fractures. Other authors report
considerably lower complication rates for intramedullary
nailing ranging from 2 to 6%, but it must be mentioned
that impending fractures account for approximately 60-
67% in these studies [5,7,8]. Many authors of larger
series advocate arthroplasty in favor of osteosynthesis in
metastases of the proximal femur because of superior
durability and lower complication rates [4,8,9]. Our
complication rate of 25% in the prosthesis group com-
pared well to the results of Harvey et al. [9]. Neverthe-
less, this is higher than the 3-10% several others authors
have reported [4,5,8]. A reason for our higher dislocation
rate might be, that 50% received a total arthroplasty
which is associated with substantially higher dislocation
rates than hemiarthroplasty in this setting [4,21]. Most
other studies use hemiarthroplasty in the vast majority
of cases [4,8,9], explaining a lower complication rate in
this respect. Additionally, regular or long-stemmed revi-
sion femoral components are widely used [4,8,22] preser-
ving the greater trochanter and subsequently improving
hip joint stability. In order to improve safety and reduce
the higher dislocation risk of proximal femoral replace-
ments, preservation and repair of the hip capsule as well
as applying a bipolar head whenever possible is recom-
mended [9]. If preservation of the capsule is not possible,
attachment tubes for soft tissue reconstruction or tripolar
cups might help in reducing the risk of dislocation [23].
Both options were not performed in our patients except in
one (Figure 3).
Preoperative general health status is an important par-
ameter in predicting survival in patients with skeletal
metastases [11,12]. Unfortunately, many authors do not
report on this [4,5,9]. As for our study groups we dem-
onstrated a significant difference suggesting a profound
Figure 3 Proximal femoral replacement arthroplasty. A) Preoperative X-ray, a.p. view. B) Completely resected proximal femur including the
pathologic fracture, soft-tissues and capsule left in situ. C) Intraoperative view of a proximal femoral replacement after reconstruction of the
capsule. D) Postoperative X-ray showing the prosthesis with a bipolar head, a.p. view.
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a poor preoperative health condition were treated with
an intramedullary nail and patients with moderate to
good general performance received endoprosthetic re-
construction. It should be mentioned that two out of
four patients with a good preoperative general health
condition and normal ambulatory capacity in the osteo-
synthesis group sustained a hardware failure. This is
in contrast to the results of Steensma et al. [8]. They
reported a preoperative Eastern Cooperative Oncology
Group (ECOG) Score of 2 points or less in 88% of
patients treated with an intramedullary nail (IM) com-
pared to only 61% in the endoprosthesis group. That
means almost all patients in the IM group were ambula-
tory and had a moderate to very good preoperative health
status preoperatively. Nevertheless, a good health status
and a subsequently higher activity of patients did not con-
tribute to a higher implant related complication rate after
nailing which was 6.1% and is considerably lower than in
our IM group. A possible explanation might be the rela-
tively high rate of impending fractures (70%) as discussed
above [8].
Despite the relatively small number of patients our
study holds several strengths compared to other larger
series [4,7-9]. First, we focused on the actual pathologic
fracture and its corresponding characteristic features
outlined above, exclusively. Second, we included only pa-
tients with multiple osseous metastases and fracture
location in the proximal femur, excluding further poten-
tial confounding variables. Third, we addressed the pre-
operative general health performance which is a majorprognostic factor in patient survival and correspondingly
supported interpretation of survival data which is rarely
reflected in other studies. On the other hand, several
limitations of our study must be mentioned. First, the
retrospective design and relatively small number of pa-
tients in the study comprise familiar limitations by itself.
Nevertheless, actual pathologic fractures are quite rare
and survival of patients is limited qualifying this type
of study. Second, many different types of cancer were
included. However, distribution of cancer type accor-
ding to aggressiveness [12] was comparable with ap-
proximately 60% of slow to moderate growth types in
each group. Third, adjuvant and neoadjuvant therapy
was not considered. But a wide divergence of treatment
protocols and unclear effectiveness [22] precluded inclu-
sion of this criterion.
Conclusion
In summary, pathologic fractures are treated equally safe
by osteosynthesis using an intramedullary nail or prox-
imal femoral resection and endoprosthetic reconstruc-
tion. Patient survival was not influenced by type of
surgery or choice of implant. Patients that show a good
to moderate general health status and are ambulatory
preoperatively might benefit from primary endopros-
thetic reconstruction due to longer implant durability.
The only concerning complication after proximal fem-
oral resection and endoprosthetic reconstruction in our
series was dislocation which must be prevented in order
to see a clear benefit over intramedullary nailing in pa-
tients with expected longer survival.
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